You will design and conduct scientific research and write papers for scientific journals, which together will also form the basis for your thesis. You will design, set-up and analyze an international patient preference study regarding remote decentralized clinical trial (RDCT) approaches and their alternatives and publish on the results, in collaboration with the Trials@Home consortium. You will also investigate other aspects of RDCTs, e.g. how they might facilitate the conduct of pragmatic trials. Other interesting research topics may arise during the project and you will have the opportunity to shape those topics to a large extent. Your work will also contribute to the final recommendations of the Trials@Home project regarding the implementation of RDCTs. About 10% of your time will be used for teaching purposes. The employment starts with 1 year. After a positive evaluation the employment will be extended with 2 years. You will get the opportunity to follow a postgraduate master program in epidemiology.
The 5-year IMI Trials@Home project (www.trialsathome.com) aims to reshape clinical trial design, conduct and operations by developing and piloting standards, recommendations and tools for the definition and acceptance of Remote Decentralised Clinical Trials (RDCT) in Europe. These trials move clinical trial activities from the clinic to the participant’s immediate surroundings using – digital – innovations. Different work packages will identify best practices for RDCT; identify and assess suitable technologies for deployment in RDCT; map the regulatory, legal and ethical framework for RDCT and determine the influence on ‘patient-health care provider interaction’ in RDCT. A pan-EU pilot trial to test the proposed approaches will be a central part of this project.
The Julius Center for Health Sciences and Primary Care is the academic coordinator for the IMI Trials@Home project. The Julius Center is one of the 11 divisions within the University Medical Center Utrecht (UMC Utrecht) and has a specific interest in clinical trial innovation. The Julius Center aspires to an international leadership role in obtaining and disseminating knowledge in the field of health sciences and primary care medicine. It has acquired a leading position by focusing on 3 pillars: ground-breaking research, successful education programs and academic primary care. The Julius Global Health group aims to build human capacity and infrastructures to improve health throughout the world.
We are looking for an inquisitive, driven researcher who can design, set-up, analyze and publish a patient preference study as well as other scientific research projects, as part of a broader project in a large multistakeholder consortium. The successful candidate will have a MSc in a relevant discipline (biomedical sciences, health sciences, medicine, drug innovation, epidemiology or similar) and an interest in the methodology and operations of clinical trials, the patient role in such trials, as well as the use of technological solutions in this field. Experience with patient preference studies and clinical (drug) trials are an advantage. You must have proven writing ability, strong problem-solving and communication skills, and fluency in English. You can work independently in a multi-disciplinary team and are interested in collaborating with different partners and stakeholders locally and internationally.
We believe in the power of a diverse team in which there is room for different skills, expertise, and social and cultural backgrounds. We invite you to respond to this vacancy.
The maximum salary for this position (32 - 36 hours) is € 3.196,00 gross per month based on full-time employment.
In addition, we offer an annual benefit of 8.3%, holiday allowance, travel expenses and career opportunities. The terms of employment are in accordance with the Cao University Medical Centers (UMC).
If you have any questions about this vacancy, please contact Mira Zuidgeest, Assistant Professor, phone number: 0031611334698, e‑mail adress: email@example.com.
Acquisition based on this jobopening is not appreciated.